Evidence map›Paper›PMID 35330476›Full record

ArticleJournal of personalized medicine2022

Exploring Rare Disease Patient Attitudes and Beliefs regarding Genetic Testing: Implications for Person-Centered Care.

Andrew A Dwyer, Melissa K Uveges, Samantha Dockray, Neil Smith

Registry-linked trialAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04733274 (Patient and Healthcare Professional Views on Genetic/Genomic Information and Testing), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04733274 active not recruitingnot on this map

Patient and Healthcare Professional Views on Genetic/Genomic Information and Testing

TypeobservationalSponsorBoston CollegeRan2018 to 2025Enrolled227ConditionsHypogonadism, Hypogonadotropic, Kallmann Syndrome
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Nursing's Role in Advancing Care for Rare Genetic Diseases.The Nursing clinics of North America · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrew A DwyerMassachusetts General Hospital-Harvard Center for Reproductive Medicine, Boston, MA 02114, USA.ORCID 0000-0002-7023-6794
Melissa K UvegesWilliam F. Connell School of Nursing, Boston College, Chestnut Hill, MA 02467, USA.
Samantha DockraySchool of Applied Psychology, University College Cork, T12 YN60 Cork, Ireland.
Neil SmithHYPOHH Patient Support Group, London WD3 1FX, UK.

Funding

The Massachusetts General Hospital Harvard Center for Reproductive MedicineP50HD104224 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI TALKOWSKI, MICHAEL E · 2021 to 2025
$7.8M
Eunice Kennedy Shriver National Institute of Child Health and Human Development 1P50HD104224-01NICHD NIH HHS P50 HD104224
6 · The paper itself

Abstract

Most rare diseases are genetic in etiology and characterized by a 'diagnostic odyssey'. Genomic advances have helped speed up the diagnosis for many rare disorders, opening new avenues for precision therapies. Little is known about patient attitudes, experiences, and beliefs about genetic testing for the rare disease congenital hypogonadotropic hypogonadism (CHH).

methodsWe conducted six focus groups with patients with CHH (

resultsMajor themes relating to pre-test experiences were 'attitudes & beliefs' (most frequently cited theme), which revealed altruism as a strong motivator for pursuing research testing and 'information and support,' which revealed a striking lack of pre-testing decisional support/genetic counseling. Major post-test themes included 'return of results,' revealing frustration with the lack of return of results and limited emotional support, and 'family communication,' describing challenging intrafamilial communication. Themes describing ethical concerns (i.e., privacy, use of samples) were least frequently noted and related to pre- and post-test experiences.

conclusionsPatients with CHH are highly motivated by altruism when pursuing testing but have significant unmet needs for pre-test decisional support and post-test counseling. It is regarded that patient values, beliefs and experiences can inform more person-centered approaches to genetic testing for rare diseases.

Indexed as

decision makingethicsgenetic counselinggenetic testinghypogonadotropic hypogonadismKallmann syndromeperson-centered carequalitative research methodsrare diseaserisk communication

Identifiers

PMID35330476
PMCPMC8955005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.